{
  "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f",
  "docSlug": "085543019d5934281487d90fc26e88a2",
  "documentTitle": "argenx SE | Results Presentation Deck | 15 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 15,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a split-screen layout to contrast established proof-of-concept (left) with future development plans (right).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/6",
  "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f",
  "deckJsonHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json",
  "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.4,
        "x": 0.55,
        "y": 0.55
      },
      "kind": "callout",
      "text": "On track to start proof-of-concept studies: Dermatomyositis, Delayed Graft Function in Kidney Transplant",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e17d1044-6023-4870-ab3e-7f900c934343",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.38,
        "x": 0.07,
        "y": 0.35
      },
      "kind": "image",
      "text": "Antibody diagram showing sweeping mechanism",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9002613e-9c50-4203-8c60-b48d10137387",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.55,
        "y": 0.33
      },
      "kind": "list",
      "text": "Enrolling second cohort; Topline ARDA results expected from both cohorts in 2024",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "10659833-a768-456a-93b8-7b9ff8964689",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.4,
        "x": 0.07,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "Favorable safety and tolerability profile",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "104e5d61-d80e-40e2-9c63-5a7a997e0fd9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.8,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "Empasiprubart: Opportunity Across Multiple Autoimmune Diseases",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1d51ebd6-9e36-4295-b255-2355a9a6c731",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 6,
      "beatId": "e5d868bb-c506-47e5-9a5e-b29673084011",
      "arcName": "The Golden Circle",
      "arcSlug": "golden-circle",
      "beatName": "Roadmap",
      "beatSlug": null,
      "evidence": "Empasiprubart: Opportunity Across Multiple Autoimmune Diseases",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 6,
      "name": "Maturity Curve",
      "slug": "36-maturity-curve",
      "bestFor": "Digital transformation, capability building, benchmarking",
      "matchId": "230fe403-8201-4db8-b7ec-38b6ac18620a",
      "evidence": "The roadmap shows the potential for empasiprubart across diseases",
      "position": 2,
      "objective": "Show the opportunity across multiple autoimmune diseases",
      "structure": "Current Maturity Level -> The Gap to Next Level -> Required Capabilities -> The Roadmap",
      "confidence": 0.6,
      "description": "Show where you are on a progression and what it takes to reach the next level"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}